Incidence of influenza A(H1N1) pdm09 infection, United Kingdom, 2009-2011

Emerging Infectious Diseases

Volumn 19, Issue 11, 2013, Pages 1866-1869

  Sridhar, Saranya ^a   Begom, Shaima ^a   Bermingham, Alison ^b   Hoschler, Katja ^b   Adamson, Walt ^c   Carman, William ^c   Van Kerkhove, Maria D ^a   Lalvani, Ajit ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADULT; ARTICLE; COHORT ANALYSIS; EPIDEMIC; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION RISK; INFLUENZA VIRUS A H1N1 PDM09; MALE; MORBIDITY; NORMAL HUMAN; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SEROPREVALENCE; UNITED KINGDOM; VIRUS STRAIN;

ADULT; COHORT STUDIES; ENGLAND; EPIDEMIOLOGY; HUMAN INFLUENZA; INCIDENCE; INFLUENZA A(H1N1)PDM09; NATURAL INFECTION; PANDEMIC INFLUENZA; PANDEMICS; SEROEPIDEMIOLOGY; SEROPREVALENCE; UNITED KINGDOM; VIRUSES;

ADULT; ANTIBODIES, VIRAL; FEMALE; GREAT BRITAIN; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MALE; PUBLIC HEALTH SURVEILLANCE; SEASONS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84886998829     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1911.130295     Document Type: Article

References (14)

1. Chen MI, Lee VJ, Barr I, Lin C, Goh R, Lee C, et al. Risk factors for pandemic (H1N1) 2009 virus seroconversion among hospital staff, Singapore. Emerg Infect Dis. 2010; 16: 1554-61. http://dx. doi. org/10. 3201/eid1610. 100516.
2. Riley S, Kwok KO, Wu KM, Ning DY, Cowling BJ, Wu JT, et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med. 2011; 8: e1000442. http://dx. doi. org/10. 1371/journal. pmed. 1000442.
3. Horby P, Mai le Q, Fox A, Thai PQ, Thi Thu Yen N, Thanh le T, et al. The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I. Am J Epidemiol. 2012; 175: 1062-74. http://dx. doi. org/10. 1093/aje/kws121.
4. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess. 2010; 14: 115-92.
5. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009; 361: 1945-52. http://dx. doi. org/10. 1056/NEJMoa0906453.
6. Adamson WE, McGregor EC, Kavanagh K, McMenamin J, McDonagh S, Molyneaux PJ, et al. Population exposure to a novel influenza A virus over three waves of infection. J Clin Virol. 2011; 52: 300-3. http://dx. doi. org/10. 1016/j. jcv. 2011. 08. 019.
7. Hoschler K, Thompson C, Andrews N, Galiano M, Pebody R, Ellis J, et al. Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011. Emerg Infect Dis. 2012; 18: 1894-7. http://dx. doi. org/10. 3201/eid1811. 120720.
8. Ross TM, Hairong L, Chia BS, Hill E, Weirback H, Zimmer S. Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA. PLoS Curr. 2011; 3: RRN1265. http://dx. doi. org/10. 1371/currents. RRN1265.
9. Orsted I, Molvadgaard M, Nielsen HL, Nielsen H. The first, second and third wave of pandemic influenza A (H1N1)pdm09 in North Denmark Region 2009-2011: a population-based study of hospitalizations. Influenza Other Respi Viruses. 2013; 7: 776-82.
10. Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respi Viruses. 2013; 7: 872-86. http://dx. doi. org/10. 1111/irv. 12074.
11. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010; 375: 1100-8. http://dx. doi. org/10. 1016/S0140-6736(09)62126-7.
12. Cauchemez S, Horby P, Fox A, Mai le Q, Thanh le T, Thai PQ, et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog. 2012; 8: e1003061. http://dx. doi. org/10. 1371/journal. ppat. 1003061.
13. Sridhar S, Begom S, Bermingham A, Ziegler T, Roberts KL, Barclay WS, et al. Predominance of heterosubtypic IFN-gammaonly-secreting effector memory T cells in pandemic H1N1 naive adults. Eur J Immunol. 2012; 42: 2913-24. http://dx. doi. org/10. 1002/eji. 201242504.
14. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013; 19: 1305-12.